We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-6 of 6

The TPP new rights for pharmaceutical patent holders in Canada
  • Gowling WLG
  • Canada
  • November 13 2015

The Canadian Government released the official consolidated text of the Trans-Pacific Partnership (TPP) agreement on Nov., 5, 2015. This follows the

The Trans-Pacific partnership: changes for patents and pharmaceuticals?
  • Gowling WLG
  • Asia-Pacific, Canada
  • October 8 2015

Changes may be on the horizon for Canada’s legal and regulatory regime for patents and pharmaceuticals. Included in the Trans-Pacific Partnership

U.S. patients receive greater access to unapproved medications
  • Gowling WLG
  • USA
  • August 21 2009

Seriously ill patients will have greater and easier access to unapproved medicines due to new USFDA regulations.

U.S. bill considers access to Canadian pharmaceuticals
  • Gowling WLG
  • USA, Canada
  • July 27 2009

Recently, the U.S. Senate amended the $43 billion Department of Homeland Securities Bill to allow Americans to purchase prescription drugs from Canadian internet pharmacies.

PMPRB lacks jurisdiction over foreign sales of medicines made available to Canadians
  • Gowling WLG
  • Canada
  • May 4 2009

In a recent decision, the Federal Court held that the Patented Medicine Price Review Board ("the Board") does not have jurisdiction to regulate sales of medicines made available to Canadians under a Special Access Program ("SAP") if the sale of the medicine occurs outside Canada.